CraigEColeMD
Hematology • Lansing, MIClotting Disorder, Hematologic Oncology
Gundersen Lutheran center for cancer and blood disorders
Dr. Cole is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
401 W Greenlawn Ave
Lansing, MI 48910Phone+1 517-975-9500Fax+1 517-975-9520
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2001- University of MichiganResidency, Internal Medicine, 1999
- University of MichiganInternship, Internal Medicine, 1995 - 1996
Ohio State University College of MedicineClass of 1995
Certifications & Licensure
MI State Medical License 1995 - 2026
IA State Medical License 2010 - 2014
MN State Medical License 2010 - 2014
WI State Medical License 2003 - 2013- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- 10 citationsAddressing the disparities: the approach to the African American patient with multiple myeloma.Manisha Bhutani, Brandon J Blue, Craig Cole, Ashraf Z Badros, Saad Z Usmani
Blood Cancer Journal. 2023-12-18 - 392 citationsOral selinexor-dexamethasone for triple-class refractory multiple myelomaAjai Chari, Dan T Vogl, Maria Gavriatopoulou, Ajay K. Nooka, Andrew Yee
The New England Journal of Medicine. 2019-08-21 - 28 citationsThe genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.Josh N Vo, Yi-Mi Wu, Jeanmarie Mishler, Sarah Hall, Rahul Mannan
Nature Communications. 2022-06-29
Abstracts/Posters
- Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrang...Craig E. Cole, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Aneuploidy Is Associated with Inferior Survival in Relapsed Refractory Multiple Myeloma PatientsCraig E. Cole, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Influence of Cytogenetics in Patients with Relapsed Refractory Multiple Myeloma Treated with Oral Selinexor and Dexamethasone: A Post-Hoc Analysis of the STORM StudyCraig E. Cole, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Exercise: A Prescription for Almost Any ConditionSeptember 14th, 2022- This May Be Democrats’ Best Chance to Lower Drug PricesOctober 27th, 2021
- Pulling Back the Curtain: Craig Cole, MDMay 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
